Covishield-like vaccine reports success in monkey trials against Nipah virus
The Hindu
No approved vaccine yet exists for the lethal virus that has killed a 12-year old boy in Kozhikode
Can a Covishield-like vaccine give protection against the ? Preliminary animal trial results seem to suggest so. In July, researchers at the Jenner Institute, Oxford University and the National Institutes of Health, United States, reported that the ChadOx1 vaccine vector, when customised to the Nipah virus, fully protected African green monkeys, a primate species. No approved vaccine yet exists for the lethal Nipah virus that has killed a, Kerala. An outbreak of the virus in the State in 2018 killed 17 of the 18 confirmed with the virus. The study appears on the pre-print server bioRxiv, indicating that it is yet to be peer-reviewed. ChAdOx1 is a multi-purpose vaccine vector, meaning it can be customised to carry DNA from a wide variety of pathogens. The version of ChAdOx1 that goes into human arms as Covishield or AstraZeneca is the ChAdOx1 with a piece of spike protein of the Sarscov2.More Related News
Bombay HC notice to Centre, Maharashtra on PIL plea seeking cancer warning labels on alcohol bottles
Bombay High Court issues notices for cancer warning labels on alcohol bottles, citing health risks and legal obligations.